Assessment and management of severe asthma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000402:Airway Obstruction; D000628:Aminophylline / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D002245:Carbon Dioxide / Q000097:blood; D002648:Child; D003490:Cyanosis / Q000209:etiology; D004562:Electrocardiography; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D012123:Pulmonary Ventilation; D011674:Pulse; D013902:Radiography, Thoracic; D012126:Respiratory Dead Space; D013147:Spirometry; D013183:Sputum / Q000382:microbiology; D013752:Tetracycline / Q000627:therapeutic use; D014797:Vital Capacity
D002245:Carbon Dioxide; D000628:Aminophylline; D009921:Metaproterenol; D013752:Tetracycline; D010100:Oxygen; D011241:Prednisone; D006854:Hydrocortisone